Home » Topics » BioWorld Science

BioWorld Science
RSS

Alchemedicine discovers CK1 and/or TGFBR1 inhibitors

Jan. 13, 2022

Roche synthesizes new Mat2A inhibitors

Jan. 13, 2022

AstraZeneca identifies new PARP-1 inhibitors

Jan. 13, 2022

Merck Sharp & Dohme presents new SCN10A blockers

Jan. 13, 2022

Autobahn Therapeutics patents thyroid hormone receptor agonists

Jan. 13, 2022

Researchers unveil SEC61 targeting as an approach for treating multiple myeloma

Jan. 13, 2022

Identification and in vivo evaluation of novel potential P2Y12 receptor PET tracers

Jan. 13, 2022

Novel 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as inhibitors of SARS-CoV-2 RdRp

Jan. 13, 2022

PTP1B inhibition enhances T-cell and CAR T-cell antitumor immunity

Jan. 13, 2022

Targeting GNAO1 presents a new therapeutic strategy for heart failure

Jan. 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...